23 July 2012

NUH continues to invest in world-class cancer treatment

NUH continues to invest in world-class cancer treatment

NUH is continuing to invest in its treatment of cancer patients with the installation of a new £1.5m Image Guided Radiotherapy (IGRT) linac machine.

The new equipment, which will be delivered in August, enables patients to be given targeted cancer treatment minimising side effects for patients.

IGRT machines allow radiographers to deliver more accurate treatment by producing an image of the inside of the patient so radiation doses can be targeted more precisely.

The machine, which is believed to be only the third of its type to be installed in the country, will also enable radiographers to carry out more complex treatments in shorter amounts of time.

The new equipment replaces a 10-year-old machine that had reached the end of its operational life and will be the Trust's fifth imaged guided linac machine.

In addition, NUH has invested in upgrading another four-year-old linac machine ensuring that the Trust continues to deliver world-class cancer treatment.

Dr Keith Langmack, Head of Clinical Radiotherapy Physics at NUH, said: "The new machine means we are able to deliver state-of-the-art radiotherapy services. The equipment has a CT scanner onboard which the previous machine did not have and is the Trust's fifth image guided machine.

"The machine is also more accurate and quicker which means the patients spend less time in the machine."

Russell Hart, Radiotherapy Service Manager, said: "It is excellent news for our patients that the Trust has the vision to invest this money in radiotherapy. This follows the £21m spent on the new radiotherapy centre opened at the City Hospital in 2010.

"This means we can continue to deliver world-class treatment for our patients at a time when many trusts are not replacing equipment due to financial pressures."

Radiotherapy is a significant component of the treatment of 40 per cent of all patients who are cured of their cancer. Timely access to radiotherapy should improve cancer outcome and survival.

Radiotherapy is more targeted than chemotherapy and less invasive than surgery. As it is a more directed form of treatment than chemotherapy there are fewer side effects on the rest of the body and it can also spare patients from radical surgery. Also new faster and more precise technologies reduce the need for long-term treatment for common side effects.

NHS Nottingham University Hospitals
Cookie Disclaimer

Our website uses cookies to provide you with a better online experience. If you continue to use our site without changing your browser settings, we'll assume you are happy to receive cookies. Please read our Cookie policy for more information.